Circulating Vascular Adhesion Protein-1 Level Predicts the Risk of Cardiovascular Events and Mortality in Hemodialysis Patients
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Dae Kyu | - |
dc.contributor.author | Lee, Yu Ho | - |
dc.contributor.author | Kim, Jin Sug | - |
dc.contributor.author | Kim, Yang Gyun | - |
dc.contributor.author | Lee, So-Young | - |
dc.contributor.author | Ahn, Shin Young | - |
dc.contributor.author | Lee, Dong-Young | - |
dc.contributor.author | Jeong, Kyung Hwan | - |
dc.contributor.author | Lee, Sang-Ho | - |
dc.contributor.author | Hwang, Hyeon Seok | - |
dc.contributor.author | Moon, Ju-Young | - |
dc.date.accessioned | 2022-12-12T02:42:08Z | - |
dc.date.available | 2022-12-12T02:42:08Z | - |
dc.date.created | 2022-12-08 | - |
dc.date.issued | 2021-09-07 | - |
dc.identifier.issn | 2297-055X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/147137 | - |
dc.description.abstract | Background: Vascular adhesion protein-1 (VAP-1) is an oxidative enzyme of primary amines that facilitates the transmigration of inflammatory cells. Its oxidative and inflammatory effects are prominently increased in pathological conditions, such as metabolic, atherosclerotic, and cardiac diseases. However, the clinical significance of circulating VAP-1 levels in hemodialysis (HD) patients is unclear. Methods: A total of 434 HD patients were enrolled in a prospective multicenter cohort study between June 2016 and April 2019. Plasma VAP-1 levels were measured at the time of data entry, and the primary endpoint was defined as a composite of cardiovascular (CV) and cardiac events. Results: Circulating VAP-1 levels were positively correlated with plasma levels of cardiac remodeling markers, including brain natriuretic peptide, galectin-3, and matrix metalloproteinase-2. Multivariable logistic regression analysis revealed that patients with higher circulating VAP-1 levels were more likely to have left ventricular diastolic dysfunction [odds ratio, 1.40; 95% confidence interval [CI], 1.04-1.88]. The cumulative event rate of the composite of CV events was significantly greater in VAP-1 tertile 3 than in VAP-1 tertiles 1 and 2 (P = 0.009). Patients in tertile 3 were also associated with an increased cumulative event rate of cardiac events (P = 0.015), with a 2.06-fold higher risk each for CV (95% CI, 1.10-3.85) and cardiac (95% CI, 1.03-4.12) events after adjusting for multiple variables. Conclusions: Plasma VAP-1 levels were positively associated with left ventricular diastolic dysfunction and the risk of incident CV and cardiac events in HD patients. Our results indicate that VAP-1 may aid clinicians in identifying HD patients at a high risk of CV events. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | FRONTIERS MEDIA SA | - |
dc.subject | SENSITIVE AMINE OXIDASE | - |
dc.subject | REDUCED EJECTION FRACTION | - |
dc.subject | CHRONIC KIDNEY-DISEASE | - |
dc.subject | HEART-FAILURE | - |
dc.subject | EUROPEAN ASSOCIATION | - |
dc.subject | AMERICAN SOCIETY | - |
dc.subject | TERMINAL PROBNP | - |
dc.subject | RENAL-FUNCTION | - |
dc.subject | ECHOCARDIOGRAPHY | - |
dc.subject | RECOMMENDATIONS | - |
dc.title | Circulating Vascular Adhesion Protein-1 Level Predicts the Risk of Cardiovascular Events and Mortality in Hemodialysis Patients | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Ahn, Shin Young | - |
dc.identifier.doi | 10.3389/fcvm.2021.701079 | - |
dc.identifier.wosid | 000697332800001 | - |
dc.identifier.bibliographicCitation | FRONTIERS IN CARDIOVASCULAR MEDICINE, v.8 | - |
dc.relation.isPartOf | FRONTIERS IN CARDIOVASCULAR MEDICINE | - |
dc.citation.title | FRONTIERS IN CARDIOVASCULAR MEDICINE | - |
dc.citation.volume | 8 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Cardiac & Cardiovascular Systems | - |
dc.subject.keywordPlus | SENSITIVE AMINE OXIDASE | - |
dc.subject.keywordPlus | REDUCED EJECTION FRACTION | - |
dc.subject.keywordPlus | CHRONIC KIDNEY-DISEASE | - |
dc.subject.keywordPlus | HEART-FAILURE | - |
dc.subject.keywordPlus | EUROPEAN ASSOCIATION | - |
dc.subject.keywordPlus | AMERICAN SOCIETY | - |
dc.subject.keywordPlus | TERMINAL PROBNP | - |
dc.subject.keywordPlus | RENAL-FUNCTION | - |
dc.subject.keywordPlus | ECHOCARDIOGRAPHY | - |
dc.subject.keywordPlus | RECOMMENDATIONS | - |
dc.subject.keywordAuthor | vascular adhesion protein-1 | - |
dc.subject.keywordAuthor | hemodialysis | - |
dc.subject.keywordAuthor | cardiovascular disease | - |
dc.subject.keywordAuthor | endothelial dysfunction | - |
dc.subject.keywordAuthor | diastolic dysfunction | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.